Claudia Mailander
Nuernberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Management and disease burden of children and adults with severe IgE-mediated food allergy: Are adults the lost population?
Journal: The World Allergy Organization journal
Published: April 16, 2024
Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL.
Journal: The World Allergy Organization journal
Published: November 25, 2022
Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: June 03, 2020
Home Self-Administration of Biologics - A German Survey among Omalizumab-Treated Patients with Severe Asthma and their Treating Physicians.
Journal: Pneumologie (Stuttgart, Germany)
Published: January 15, 2020
The Long-Term Effectiveness and Safety of Omalizumab on Patient- and Physician-Reported Asthma Control: A Three-Year, Real-Life Observational Study.
Journal: Advances in therapy
Published: September 18, 2019
Patterns of allergen sensitization in patients with severe asthma in Germany.
Journal: The journal of allergy and clinical immunology. In practice
Published: August 13, 2019
"Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
Journal: International journal of chronic obstructive pulmonary disease
Published: February 17, 2017
A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
Journal: Respiratory medicine
Published: October 20, 2016
A year in the life of German patients with COPD: the DACCORD observational study.
Journal: International journal of chronic obstructive pulmonary disease
Published: August 09, 2016
Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial.
Journal: Pulmonary pharmacology & therapeutics
Published: July 21, 2016
Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study).
Journal: BMC pulmonary medicine
Published: March 18, 2016
The 'real-life' COPD patient in Germany: The DACCORD study.
Journal: Respiratory medicine
Published: July 17, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026